MX2024000570A - Prueba basada en hisopo oral para detectar varios estados de una enfermedad en gatos domesticos. - Google Patents
Prueba basada en hisopo oral para detectar varios estados de una enfermedad en gatos domesticos.Info
- Publication number
- MX2024000570A MX2024000570A MX2024000570A MX2024000570A MX2024000570A MX 2024000570 A MX2024000570 A MX 2024000570A MX 2024000570 A MX2024000570 A MX 2024000570A MX 2024000570 A MX2024000570 A MX 2024000570A MX 2024000570 A MX2024000570 A MX 2024000570A
- Authority
- MX
- Mexico
- Prior art keywords
- disease states
- detection
- domestic cats
- various disease
- based test
- Prior art date
Links
- 241000282326 Felis catus Species 0.000 title abstract 2
- 238000001514 detection method Methods 0.000 title 1
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 208000017701 Endocrine disease Diseases 0.000 abstract 1
- 208000030172 endocrine system disease Diseases 0.000 abstract 1
- 230000002757 inflammatory effect Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 238000012216 screening Methods 0.000 abstract 1
- 230000002485 urinary effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
- C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/60—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to nutrition control, e.g. diets
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Medical Informatics (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Pathology (AREA)
- Primary Health Care (AREA)
- Genetics & Genomics (AREA)
- Data Mining & Analysis (AREA)
- Databases & Information Systems (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Nutrition Science (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Measuring And Recording Apparatus For Diagnosis (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163221559P | 2021-07-14 | 2021-07-14 | |
| US202163221558P | 2021-07-14 | 2021-07-14 | |
| PCT/US2022/073735 WO2023288273A1 (en) | 2021-07-14 | 2022-07-14 | Oral swab-based test for the detection of various disease states in domestic cats |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2024000570A true MX2024000570A (es) | 2024-01-29 |
Family
ID=84919697
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2024000570A MX2024000570A (es) | 2021-07-14 | 2022-07-14 | Prueba basada en hisopo oral para detectar varios estados de una enfermedad en gatos domesticos. |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20240301514A1 (https=) |
| EP (1) | EP4370714A4 (https=) |
| JP (1) | JP2024525776A (https=) |
| KR (1) | KR20240033007A (https=) |
| CA (1) | CA3224390A1 (https=) |
| MX (1) | MX2024000570A (https=) |
| WO (1) | WO2023288273A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3215003A1 (en) * | 2021-04-22 | 2022-10-27 | Damian KAO | Oral swab-based test for the detection of dental disease states in domestic cats, dogs and other mammals |
| US20230348951A1 (en) * | 2022-04-28 | 2023-11-02 | Société des Produits Nestlé S.A. | Diagnosing and treating chronic kidney disease in a feline |
| KR102851116B1 (ko) | 2024-10-31 | 2025-08-27 | 주식회사 리비오젠 | 반려동물 치주질환 조기 진단용 구강 마이크로바이옴 검사 시스템 및 검사 방법 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20180030516A1 (en) * | 2015-02-27 | 2018-02-01 | Alere Inc. | Microbiome Diagnostics |
| US10246704B1 (en) * | 2017-12-29 | 2019-04-02 | Clear Labs, Inc. | Detection of microorganisms in food samples and food processing facilities |
| EP3917407A1 (en) * | 2019-02-01 | 2021-12-08 | Mars Incorporated | Kit, method, and device for sampling oral microbiome |
| US20230016526A1 (en) * | 2019-12-03 | 2023-01-19 | Animal Microbiome Analytics, Inc. (D/B/A Animalbiome) | System and methods for manipulation of the oral microbiome in mammals |
| CA3215003A1 (en) * | 2021-04-22 | 2022-10-27 | Damian KAO | Oral swab-based test for the detection of dental disease states in domestic cats, dogs and other mammals |
-
2022
- 2022-07-14 KR KR1020247004687A patent/KR20240033007A/ko active Pending
- 2022-07-14 MX MX2024000570A patent/MX2024000570A/es unknown
- 2022-07-14 CA CA3224390A patent/CA3224390A1/en active Pending
- 2022-07-14 JP JP2024501959A patent/JP2024525776A/ja active Pending
- 2022-07-14 WO PCT/US2022/073735 patent/WO2023288273A1/en not_active Ceased
- 2022-07-14 EP EP22843051.8A patent/EP4370714A4/en active Pending
- 2022-07-14 US US18/578,289 patent/US20240301514A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20240301514A1 (en) | 2024-09-12 |
| JP2024525776A (ja) | 2024-07-12 |
| EP4370714A1 (en) | 2024-05-22 |
| CA3224390A1 (en) | 2023-01-19 |
| KR20240033007A (ko) | 2024-03-12 |
| WO2023288273A1 (en) | 2023-01-19 |
| EP4370714A4 (en) | 2025-07-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2024000570A (es) | Prueba basada en hisopo oral para detectar varios estados de una enfermedad en gatos domesticos. | |
| Meklin et al. | Colorectal cancer screening with traditional and new-generation fecal immunochemical tests: a critical review of fecal occult blood tests | |
| NZ592358A (en) | Methods and compositions for diagnosis and prognosis of renal injury and renal failure using tissue inhibitor of metalloproteinase 2 (timp-2) | |
| ES2484142T3 (es) | Diagnóstico molecular y clasificación del melanoma maligno | |
| BR0311983A (pt) | Métodos para detectar células neoplásticas ativadas por ras em uma amostra biológica, para diagnosticar um neoplasma ativado por ras em um animal, para tratar ou melhorar um neoplasma ativado por ras em um animal, para diagnosticar a presença de um neoplasma em um mamìfero, para detectar células neoplásticas tendo um fenótipo particular em uma amostra biológica, para diagnosticar um neoplasma tendo um fenótipo particular em um animal, e tratar ou melhorar um neoplasma tendo um fenótipo particular em um animal | |
| ATE534911T1 (de) | Verfahren zur diagnostizierung einer entzündlichen darmerkrankung | |
| MX2023012316A (es) | Prueba a base de hisopos orales para la deteccion de estados patologicos dentarios en gatos domesticos, perros y otros mamiferos. | |
| MX2020010387A (es) | Metodos para detectar y cuantificar fgf21. | |
| NZ604873A (en) | Methods and compositions for diagnosis and prognosis of renal injury and renal failure | |
| MX2008010896A (es) | Metodo para detectar o diagnosticar una enfermedad o condicion neurodegenerativa. | |
| BR112013000869A2 (pt) | método para diagnóstico de câncer de próstata (pca) com uma sensibilidade desejada em um sujeito; método para monitorar a progressão do câncer de próstata (pca) em um sujeito; método para avaliar se um sujeito tem que ser submetido a uma biópsia de próstata; kit compreendendo um primeiro componente e, opcionalmente, um segundo componente e uso de um kit | |
| NZ630621A (en) | Methods and compositions for diagnosis and prognosis of renal injury and renal failure | |
| ZA202102071B (en) | Use of soluble trem-1 levels for identifying subjects susceptible to respond to an anti-inflammatory therapy | |
| WO2021053343A8 (en) | Methods for predicting patient response to DMARDs | |
| NZ599773A (en) | Methods and compositions for diagnosis and prognosis of renal injury and renal failure | |
| WO2007056523A3 (en) | Methods for diagnosing and monitoring the progression of cancer | |
| AU2003234549A8 (en) | Systems and methods for identifying organ transplant risk | |
| DK1214447T3 (da) | Påvisning af pyruvatkinase-isoenzymer i fæces | |
| MX2024000571A (es) | Prueba basada en hisopo oral para detectar varios estados de una enfermedad en gatos domesticos. | |
| EP1581794A4 (en) | METHOD FOR DIAGNOSIS AND TREATMENT ON CANCER | |
| ES2530574T3 (es) | Biomarcadores asociados a la nefropatía | |
| Savitz et al. | Do studies of wire code and childhood leukemia point towards or away from magnetic fields as the causal agent? | |
| Ciatto et al. | Specific features of the Italian section of the ERSPC. | |
| MX2022001786A (es) | Métodos para diagnosticar, pronosticar y monitorear el tratamiento de la trombosis en sujetos con lupus eritematoso sistémico. | |
| van Vossen-Van Den Berg et al. | Evaluation of the ability of sensor networks to detect E. coli events compared to sampling programmes |